Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Sicca syndrome (dry mouth or eyes): suspected Sjögren's disease

Internal medicine and immunology · Symptom or situation · updated 2026-10-30

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: Sjögren disease: between 1/1000 and 1/10 000 [1]

Disabling dry mouth or dry eyes: suspected Sjögren's disease

Laboratory tests (state "suspected Sjögren syndrome" on the request form)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Confirmed Sjögren's disease: laboratory monitoring

At every follow-up visit (every 3 to 6 months if active disease, every 1 to 2 years if quiescent)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Do not order

Sources (6)
  1. Centre de référence des maladies auto-immunes et systémiques rares (CeRAINO, Île-de-France), filière FAI²R. Maladie (ou syndrome) de Sjögren : synthèse à destination du médecin traitant, extraite du PNDS. Haute Autorité de santé, mars 2022.
  2. Centre de référence des maladies auto-immunes et systémiques rares (CeRAINO, Île-de-France), filière FAI²R. Protocole national de diagnostic et de soins (PNDS) : maladie (ou syndrome) de Sjögren. Haute Autorité de santé, mars 2022.
  3. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : sous-chapitre 7-03 auto-immunité, actes 1456-1457 (anti-antigènes nucléaires solubles) et conditions de recherche des anti-SSA en l'absence d'antinucléaires.
  4. Price EJ, Benjamin S, Bombardieri M, et al. British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology (Oxford). 2025;64(2):409-439.
  5. Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017;69(1):35-45.
  6. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1139 (25-OH-vitamine D) et 1828 (anticorps antitransglutaminase IgA), conditions de prise en charge.